Dt Investment Partners, LLC Biomarin Pharmaceutical Inc Transaction History
Dt Investment Partners, LLC
- $1.18 Billion
- Q4 2024
A detailed history of Dt Investment Partners, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Dt Investment Partners, LLC holds 168 shares of BMRN stock, worth $10,668. This represents 0.0% of its overall portfolio holdings.
Number of Shares
168
Previous 223
24.66%
Holding current value
$10,668
Previous $15,000
26.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BMRN
# of Institutions
645Shares Held
178MCall Options Held
2MPut Options Held
1.27M-
Black Rock Inc. New York, NY22.7MShares$1.44 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.22 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.16 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$883 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$666 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...